|
Randomized, phase II dose optimization study of chimeric antigen receptor (CAR) modified T cells directed against CD19 in patients (pts) with relapsed, refractory (R/R) CLL. |
|
|
Employment - Genentech (I) |
Stock and Other Ownership Interests - Genentech/Roche (I) |
|
Consulting or Advisory Role - Novartis; Ocata Therapeutics |
Research Funding - Novartis |
Patents, Royalties, Other Intellectual Property - Novartis; Novartis (Inst) |
Travel, Accommodations, Expenses - Immunovative Therapies |
|
|
Consulting or Advisory Role - Amgen |
Research Funding - Novartis |
|
|
Research Funding - Novartis |
Patents, Royalties, Other Intellectual Property - Novartis |
|
|
No Relationships to Disclose |
|
|
Research Funding - Novartis |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Tmunity Therapeutics, Inc. |
Patents, Royalties, Other Intellectual Property - Novartis |
|
|
Research Funding - Novartis |
|
|
Honoraria - Alexion Pharmaceuticals |
Research Funding - Novartis (Inst) |
|
|
|
|
|
Consulting or Advisory Role - Abbvie; Celgene; Gilead Sciences; Pharmacyclics |
Research Funding - Abbvie; Acerta Pharma; Gilead Sciences; Pharmacyclics; ProNAi; TG Therapeutics |
|
|
Consulting or Advisory Role - Novartis |
Research Funding - Novartis |
Travel, Accommodations, Expenses - Novartis |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Research Funding - Novartis (Inst) |
|
|
|
Stock and Other Ownership Interests - Lilly |
Patents, Royalties, Other Intellectual Property - IP, royalties, and future distributions from commercialization of CTL019 technology |
|
|
Consulting or Advisory Role - Janssen; Janssen; Jazz Pharmaceuticals; Novartis; Pfizer |
Research Funding - Novartis |
|
|
Stock and Other Ownership Interests - Tmunity Therapeutics, Inc. |
|
Consulting or Advisory Role - TERUMO |
Research Funding - Novartis; Takara Bio |
Patents, Royalties, Other Intellectual Property - intellectual property and patents in the field of cell and gene therapy |
Travel, Accommodations, Expenses - TERUMO |
|
|
Stock and Other Ownership Interests - Celldex; GlobeImmune; Immune Design |
Honoraria - MedImmune; Novartis; Pfizer |
Consulting or Advisory Role - Celldex; GlobeImmune; Immune Design |
Research Funding - Novartis |
Patents, Royalties, Other Intellectual Property - IP licensed to Novartis; Royalties paid to University of Pennsylvania; Office of Naval Research; IP and patent royalties |